FindTrial
Sign In

To assess the seriousness in COVID-19 patients with the blood test report.

Neutrophil-lymphocyte ratio and Platelet to lymphocyte ratio as markers for predicting the severity in COVID-19 patients: A Prospective Observational study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/07/026574
Enrollment
100
Registered
2020-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B349- Viral infection, unspecified

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

AIIMS Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Only confirmed cases of COVID-19 diagnosed on the basis of ICMR standard

Exclusion criteria

Exclusion criteria: 1.Age below 6 years. 2.Pregnant patients 3.Dialysis dependent patients 4.All trauma patients 5.Any malignancy 6.Any psychiatric illness 7.Consent not given

Design outcomes

Primary

MeasureTime frame
To evaluate the ability of the NLR and PLR to predict severity in COVID-19 patients. Timepoint: Baseline-on admission—

Secondary

MeasureTime frame
1. Mortality 2. Length of hospitalization 3. Mechanical ventilation Timepoint: 28 days—

Countries

India

Contacts

Public ContactYudhyavir Singh

AIIMS

yudhyavir@gmail.com9811140057

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026